References
- Morimoto K, Iwai K, Uchimura K, et al. A steady increase in nontuberculous mycobacteriosis mortality and estimated prevalence in Japan. Ann Am Thorac Soc. 2014 Jan;11(1):1–8. DOI:https://doi.org/10.1513/AnnalsATS.201303-067OC.
- Namkoong H, Kurashima A, Morimoto K, et al. Epidemiology of pulmonary nontuberculous mycobacterial disease, Japan. Emerg Infect Dis. 2016 Jun;22(6):1116–1117. DOI:https://doi.org/10.3201/eid2206.151086.
- Daley CL, Iaccarino JM, Lange C, et al. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline. Eur Respir J. 2020 Jul;56(1):2000535. DOI:https://doi.org/10.1183/13993003.00535-2020.
- Kakuta T, Tabusadani M, Yamane K, et al. Prevalence of depressive symptoms and related risk factors in Japanese patients with pulmonary nontuberculous mycobacteriosis. Psychol Health Med. 2020;23:1–8.
- Koh WJ, Moon SM, and Kim SY, et al. Outcomes of Mycobacterium avium complex lung disease based on clinical phenotype. Eur Respir J. 2017 Sep;50(3):1602503. DOI:https://doi.org/10.1183/13993003.02503-2016.
- Zheng C, Fanta CH. Non-tuberculous mycobacterial pulmonary infection in the immunocompetent host. Qjm. 2013 Apr;106(4):307–315.
- Shu CC, Lee CH, Hsu CL, et al. Clinical characteristics and prognosis of nontuberculous mycobacterial lung disease with different radiographic patterns. Lung. 2011 Dec;189(6):467–474. DOI:https://doi.org/10.1007/s00408-011-9321-4.
- Lee G, Lee KS, Moon JW, et al. Nodular bronchiectatic Mycobacterium avium complex pulmonary disease. Natural course on serial computed tomographic scans. Ann Am Thorac Soc. 2013 Aug;10(4):299–306. DOI:https://doi.org/10.1513/AnnalsATS.201303-062OC.
- Kwak N, Kim SA, Choi SM, et al. Longitudinal changes in health-related quality of life according to clinical course among patients with non-tuberculous mycobacterial pulmonary disease: a prospective cohort study. BMC Pulm Med. 2020 May 7;20(1):126. https://doi.org/10.1186/s12890-020-1165-3
- Rochester CL, Vogiatzis I, Holland AE, et al. An official American thoracic society/European respiratory society policy statement: enhancing implementation, use, and delivery of pulmonary rehabilitation. Am J Respir Crit Care Med. 2015 Dec 1;192(11):1373–1386. PubMed PMID: 26623686. DOI:https://doi.org/10.1164/rccm.201510-1966ST.
- Kozu R, Senjyu H, Jenkins SC, et al. Differences in response to pulmonary rehabilitation in idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease. Respiration. 2011;81(3):196–205. DOI:https://doi.org/10.1159/000315475.
- Lan CC, Lai SR, Chien JY. Nonpharmacological treatment for patients with nontuberculous mycobacterial lung disease. J Formos Med Assoc. 2020 Jun;119(Suppl 1):S42–S50.
- Basavaraj A, Segal L, and Samuels J, et al. Effects of chest physical therapy in patients with non-tuberculous Mycobacteria . Int J Respir Pulm Med. 2017;4(1). DOI:https://doi.org/10.23937/2378-3516/1410065.
- Singh SJ, Puhan MA, Andrianopoulos V, et al. An official systematic review of the European respiratory society/American thoracic society: measurement properties of field walking tests in chronic respiratory disease. Eur Respir J. 2014 Dec;44(6):1447–1478. DOI:https://doi.org/10.1183/09031936.00150414.
- Waschki B, Kirsten A, Holz O, et al. Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest. 2011 Aug;140(2):331–342. DOI:https://doi.org/10.1378/chest.10-2521.
- Griffith DE, Eagle G, Thomson R, et al. Amikacin Liposome inhalation suspension for treatment-refractory lung disease caused by mycobacterium avium complex (CONVERT). A prospective, open-label, randomized study. Am J Respir Crit Care Med. 2018 Dec 15;198(12):1559–1569. https://doi.org/10.1164/rccm.201807-1318OC
- Takao S, Tabusadani M, Yamane K, et al. Is the Leicester cough questionnaire useful for nontuberculous mycobacterial lung disease? Respir Investig. 2020 Aug;59(1):120–125. DOI:https://doi.org/10.1016/j.resinv.2020.06.005.
- Kawahara K, Tabusadani M, Yamane K, et al. Health-related quality of life associates with clinical parameters in patients with NTM pulmonary disease. Int J Tuberc Lung Dis. 2021 Apr 1;25(4):299–304. https://doi.org/10.5588/ijtld.20.0790
- Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007 Feb 15;175(4):367–416. https://doi.org/10.1164/rccm.200604-571ST
- Furuuchi K, Morimoto K, Yoshiyama T, et al. Interrelational changes in the epidemiology and clinical features of nontuberculous mycobacterial pulmonary disease and tuberculosis in a referral hospital in Japan. Respir Med. 2019 Jun;152:74–80.
- Singh SJ, Morgan MD, Scott S, et al. Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax. 1992 Dec;47(12):1019–1024. DOI:https://doi.org/10.1136/thx.47.12.1019.
- Itaki M, Kozu R, Tanaka K, et al. Reference equation for the incremental shuttle walk test in Japanese adults. Respir Investig. 2018 Nov;56(6):497–502. DOI:https://doi.org/10.1016/j.resinv.2018.08.005.
- Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005 Aug;26(2):319–338. DOI:https://doi.org/10.1183/09031936.05.00034805.
- Bestall JC, Paul EA, Garrod R, et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999 Jul;54(7):581–586. DOI:https://doi.org/10.1136/thx.54.7.581.
- Jones PW, Harding G, Berry P, et al. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009 Sep;34(3):648–654. DOI:https://doi.org/10.1183/09031936.00102509.
- Hama M, Ushiki A, Kosaka M, et al. Health-related quality of life in patients with pulmonary non-tuberculous mycobacteria infection. Int J Tuberc Lung Dis. 2016 Jun;20(6):747–752. DOI:https://doi.org/10.5588/ijtld.15.0460.
- Katoh M, Yamasaki H. Test-retest reliability of isometric leg muscle strength measurements made using a hand-held dynamometer restrained by a belt comparisons during and between sessions. J Phys Ther Sci. 2009 Apr;21(3):239–243.
- The National Isometric Muscle Stremgth Database Consorttium. Muscular weakness assessment. Use of normal isometric strength data. Arch Phys Med Rehabil. 1996 Dec;77(12):1251–1255.https://doi.org/10.1016/S0003-9993(96)90188-4
- Asakura T, Yamada Y, Namkoong H, et al. Impact of cavity and infiltration on pulmonary function and health-related quality of life in pulmonary Mycobacterium avium complex disease: a 3-dimensional computed tomographic analysis. Respir Med. 2017 May;126:9–16.
- Gosselink R, Troosters T, Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med. 1996 Mar;153(3):976–980.
- Broekhuizen R, Wouters EF, Creutzberg EC, et al. Raised CRP levels mark metabolic and functional impairment in advanced COPD. Thorax. 2006 Jan;61(1):17–22. DOI:https://doi.org/10.1136/thx.2005.041996.
- Ferrari M, Manea L, Anton K, et al. Anemia and hemoglobin serum levels are associated with exercise capacity and quality of life in chronic obstructive pulmonary disease. BMC Pulm Med. 2015 May 8 15(1):58. https://doi.org/10.1186/s12890-015-0050-y
- Bajaj DK, Kushwaha RAS, Srivastava A, et al. Multiple abdominal abscesses - A not so common presentation of NTM. Indian J Tuberc. 2017 Jul;64(3):225–227. DOI:https://doi.org/10.1016/j.ijtb.2016.06.005.
- Watanabe F, Taniguchi H, Sakamoto K, et al. Quadriceps weakness contributes to exercise capacity in nonspecific interstitial pneumonia. Respir Med. 2013 Apr;107(4):622–628. DOI:https://doi.org/10.1016/j.rmed.2012.12.013.
- de Camargo AA, Amaral TS, Rached SZ, et al. Incremental shuttle walking test: a reproducible and valid test to evaluate exercise tolerance in adults with noncystic fibrosis bronchiectasis. Arch Phys Med Rehabil. 2014 May;95(5):892–899. DOI:https://doi.org/10.1016/j.apmr.2013.11.019.
- Spruit MA, Singh SJ, Garvey C, et al. An official American thoracic society/European respiratory society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013 Oct 15;188(8):e13–64. https://doi.org/10.1164/rccm.201309-1634ST
- Altenburg WA, de Greef MH, ten Hacken NH, et al. A better response in exercise capacity after pulmonary rehabilitation in more severe COPD patients. Respir Med. 2012 May;106(5):694–700. DOI:https://doi.org/10.1016/j.rmed.2011.11.008.
- Zanini A, Aiello M, Adamo D, et al. Effects of pulmonary rehabilitation in patients with non-cystic fibrosis bronchiectasis: a retrospective analysis of clinical and functional predictors of efficacy. Respiration. 2015;89(6):525–533. DOI:https://doi.org/10.1159/000380771.
- Holland AE, Hill CJ, Conron M, et al. Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease. Thorax. 2008 Jun;63(6):549–554. DOI:https://doi.org/10.1136/thx.2007.088070.
- Mendes FA, Goncalves RC, Nunes MP, et al. Effects of aerobic training on psychosocial morbidity and symptoms in patients with asthma: a randomized clinical trial. Chest. 2010 Aug;138(2):331–337. DOI:https://doi.org/10.1378/chest.09-2389.
- Lee AL, Hill CJ, Cecins N, et al. The short and long term effects of exercise training in non-cystic fibrosis bronchiectasis–a randomised controlled trial. Respir Res. 2014 Apr 15 15(1):44. https://doi.org/10.1186/1465-9921-15-44
- Ando M, Mori A, Esaki H, et al. The effect of pulmonary rehabilitation in patients with post-tuberculosis lung disorder. Chest. 2003 Jun;123(6):1988–1995. DOI:https://doi.org/10.1378/chest.123.6.1988.
- Faverio P, De Giacomi F, and Bodini BD, et al. Nontuberculous mycobacterial pulmonary disease: an integrated approach beyond antibiotics. ERJ Open Res. 2021 Apr;7(2):00574–2020. DOI:https://doi.org/10.1183/23120541.00574-2020.
- Yagi K, Asakura T, and Namkoong H, et al. Association between six-minute walk test parameters and the health-related quality of life in patients with pulmonary Mycobacterium avium complex disease. BMC Pulm Med. 2018 Jul 13 ;18(1):114. https://doi.org/10.1186/s12890-018-0686-5